osteoarthritis

Broom sweep clean
Biotech

Novartis axes osteoarthritis asset and radioligand therapy

Novartis swept a phase 2 osteoarthritis prospect and first-in-human radioconjugate out of its pipeline after assessing evidence on the programs.
Nick Paul Taylor Apr 29, 2025 5:24am
X ray illustration of a running person with pain in knee joint with blue background

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Apr 16, 2025 2:55pm
In Laboratory Over the Shoulder View of Scientist in Protective Clothes Doing Research on a Personal Computer

GSK pays AI biotech $45M upfront to identify fibrotic targets

Dec 10, 2024 4:59am
knee x-ray

Levicept's ex-Pfizer drug reduces osteoarthritis pain in ph. 2

Aug 6, 2024 1:00am
closed shuttered shut down closed

Ampio prepares to wind down after final therapeutic dream dies

Mar 26, 2024 9:01am
Missed target failed trial trial failure

Ampio’s last shot at success fizzles out in preclinical stage

Feb 15, 2024 7:10am